Agency classClass IIOur severity:High FDA (Devices)·Z-0858-2013·Announced 2013-02-27

Codman NeuroPath Guiding Catheters Recalled for Potential Sterility Compromise

Codman & Shurtleff is recalling NeuroPath 5Fx100 Guiding Catheters because package integrity issues may compromise device sterility.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II. The hazard involves a potential loss of sterility in an invasive medical device, which poses a risk of harm (infection) even though specific injuries or illnesses are not reported in the source text.

Plain-English summary

Codman & Shurtleff, Inc. is recalling 46 units of the NeuroPath 5Fx100 Guiding Catheter (Product Code: GST51000000). The recall was initiated because the sterility of the device may be compromised due to a lack of package integrity. These catheters are intended for use in the coronary, peripheral, and neurovasculature for the intravascular introduction of interventional and diagnostic devices.

The affected units were distributed worldwide, including nationwide in the United States and internationally to Austria, Belgium, Canada, Chile, Costa Rica, the Czech Republic, Denmark, France, Germany, Great Britain/UK, Ireland, Italy, Lithuania, Malaysia, the Netherlands, New Zealand, Norway, Poland, Portugal, Singapore, Slovakia, Spain, and Switzerland. The recall covers all unexpired lots.

Healthcare providers and facilities should stop using the affected NeuroPath 5Fx100 Guiding Catheters immediately and contact Codman & Shurtleff, Inc. for instructions on returning the devices.

The recalled product

Product: NEUROPATH 5Fx100 GUIDING CATH ST Product Code: GST51000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices
Manufacturer: Codman & Shurtleff, Inc.
Category: Medical Device — Interventional Catheter
Hazard: sterility-compromise
infection-risk
Affected units: 46

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

All unexpired lots

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 24 recalled by Codman & Shurtleff, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 24 products in this recall →

Same manufacturer · Codman & Shurtleff, Inc.

See all →

Moderate
Codman Galaxy G3 Mini Microcoil Delivery System Recalled for Labeling Error
FDA (Devices) · 2019-08-21
High
Codman 3000 Series Refill Set Recalled for Leaking Needles
FDA (Devices) · 2015-06-03
High
Codman EDS 3 Drainage System Recalled for Tubing Leak Risk
FDA (Devices) · 2014-10-29
Severe
Codman EDS 3 Drainage System Recalled for Potential CSF Leakage
FDA (Devices) · 2014-10-29
Severe
Codman Lumbar Drainage Catheter Kit Recalled for Potential CSF Leakage
FDA (Devices) · 2014-10-29

Same hazard · sterility compromise